Taysha Gene Therapies, Inc. (TSHA) — Institutional Holders, Q2 2026 (page 3)
209 institutional investment managers reported a TSHA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.1B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 209. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
TSHA 13F holders ranked 201–209 of 209
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 201 | Covestor Ltd#201 · 94 sh | 94 | $1.0K | <0.01% | +248.1% |
| 202 | EverSource Wealth Advisors#202 · 141 sh | 141 | $960.00 | 0.00% | -99.9% |
| 203 | NATIONAL BANK OF CANADA#203 · 85 sh | 85 | $578.00 | 0.00% | New |
| 204 | Farther Finance Advisors#204 · 55 sh | 55 | $375.00 | — | 0.0% |
| 205 | True Wealth Design#205 · 30 sh | 30 | $205.00 | — | 0.0% |
| 206 | Keating Financial Advisory Services#206 · 26 sh | 26 | $177.00 | 0.00% | +100.0% |
| 207 | IFP Advisors#207 · 14 sh | 14 | $95.00 | — | 0.0% |
| 208 | Hughes Financial Services#208 · 6 sh | 6 | $41.00 | 0.00% | New |
| 209 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#209 · 169,374 sh | 169,374 | — | — | +23.7% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.